Overview
Scott Soleimanpour, M.D. is an Associate Professor of Internal Medicine, Investigator in the Brehm Diabetes Research Center, and Director of the Diabetes Transition Program at the University of Michigan Medical School. Diagnosed with type 1 diabetes (T1D) in 1986, Dr. Soleimanpour is deeply invested in basic research focused on the genetic causes of T1D while also directing a thriving clinical program that empowers diabetic young adults during their transition to self-care. Dr. Soleimanpour attended Kent State University and the Northeast Ohio Medical University as part of a combined B.S./M.D. program. During his pre-doctoral and post-doctoral research training, Dr. Soleimanpour completed diabetes research fellowships in the Vanderbilt University/NIDDK medical scholars program, the Howard Hughes Medical Institute-National Institutes of Health (HHMI-NIH) Research Scholars program, and in the William Osler Society of Fellows at the University of Pennsylvania. Among Dr. Soleimanpour’s key research contributions include studies focused on islet cell transplantation, beta cell failure after islet cell transplantation, and include recent seminal studies in understanding the genetic causes of pancreatic beta cell failure in T1D. He has received awards and honors from the Juvenile Diabetes Research Foundation, American Diabetes Association, the American Society of Clinical Investigation, the Central Society for Clinical and Translational Research, the Alpha Omega Alpha National Medical Honors Society, and The Endocrine Society. He has also been featured on the NBC Nightly News, the Philadelphia Inquirer, Medicine at Michigan, Reader’s Digest, and the PBS medical series Second Opinion. The Soleimanpour Lab has pioneered the study of mitochondrial health and quality control in pancreatic beta cells and T1D pathophysiology, and he continues to focus on how defects in T1D genes lead patients to develop diabetes.
His clinical expertise encompasses Type 1 Diabetes (T1D), Kallmann Syndrome, Sheehan Syndrome, and Hypopituitarism.
Dr. Soleimanpour is board certified in Endocrinology, Diabetes & Metabolism. Dr. Soleimanpour is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- HMO
- POS
Locations
24 Frank Lloyd Wright Dr Ste 1300, Lobby C, Ann Arbor, MI 48105
Additional Areas of Focus
Dr. Soleimanpour has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Frequently Asked Questions about Dr. Arash S. Soleimanpour
How do I make an appointment with Dr. Arash S. Soleimanpour?
You can book an appointment with Dr. Arash S. Soleimanpour by calling their office at 866-266-5221. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Arash S. Soleimanpour a top-rated expert for Type 1 Diabetes (T1D)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arash S. Soleimanpour is classified as an Experienced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Arash S. Soleimanpour specialize in?
While Dr. Arash S. Soleimanpour is a Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Kallmann Syndrome, and Sheehan Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.
Does Dr. Arash S. Soleimanpour accept my insurance?
Dr. Arash S. Soleimanpour accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 866-266-5221 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal Insufficiency PediatricDr. Soleimanpour isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Growth Hormone Deficiency (GHD)Dr. Soleimanpour isExperienced. Learn about Growth Hormone Deficiency (GHD).
- HypogonadismDr. Soleimanpour isExperienced. Learn about Hypogonadism.
- Hypogonadotropic HypogonadismDr. Soleimanpour isExperienced. Learn about Hypogonadotropic Hypogonadism.
- HypopituitarismDr. Soleimanpour isExperienced. Learn about Hypopituitarism.
- Isolated Hypogonadotropic HypogonadismDr. Soleimanpour isExperienced. Learn about Isolated Hypogonadotropic Hypogonadism.
- Kallmann SyndromeDr. Soleimanpour isExperienced. Learn about Kallmann Syndrome.
- PanhypopituitarismDr. Soleimanpour isExperienced. Learn about Panhypopituitarism.
- Pediatric Growth Hormone DeficiencyDr. Soleimanpour isExperienced. Learn about Pediatric Growth Hormone Deficiency.
- Sheehan SyndromeDr. Soleimanpour isExperienced. Learn about Sheehan Syndrome.
- Type 1 Diabetes (T1D)Dr. Soleimanpour isExperienced. Learn about Type 1 Diabetes (T1D).